269 related articles for article (PubMed ID: 33684229)
1. Mastocytosis in the skin accompanied by pseudo-Kaposi's sarcoma.
Vergara-de-la-Campa L; Torrado I; Recuero-Pradillo M; Torrelo A; Gironella M; Pardal E; Godoy AC; Matito A; Pérez-Hortet C; Mollejo M; Álvarez-Twöse I
J Dermatol; 2021 May; 48(5):657-660. PubMed ID: 33684229
[TBL] [Abstract][Full Text] [Related]
2. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
3. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
[TBL] [Abstract][Full Text] [Related]
4. Update on Mastocytosis (Part 2): Categories, Prognosis, and Treatment.
Azaña JM; Torrelo A; Matito A
Actas Dermosifiliogr; 2016; 107(1):15-22. PubMed ID: 26525106
[TBL] [Abstract][Full Text] [Related]
5. Mastocytosis and related disorders.
Chiu A; Orazi A
Semin Diagn Pathol; 2012 Feb; 29(1):19-30. PubMed ID: 22372203
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic criteria and classification of mastocytosis: a consensus proposal.
Valent P; Horny HP; Escribano L; Longley BJ; Li CY; Schwartz LB; Marone G; Nuñez R; Akin C; Sotlar K; Sperr WR; Wolff K; Brunning RD; Parwaresch RM; Austen KF; Lennert K; Metcalfe DD; Vardiman JW; Bennett JM
Leuk Res; 2001 Jul; 25(7):603-25. PubMed ID: 11377686
[TBL] [Abstract][Full Text] [Related]
7. Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.
Álvarez-Twose I; Jara-Acevedo M; Morgado JM; García-Montero A; Sánchez-Muñoz L; Teodósio C; Matito A; Mayado A; Caldas C; Mollejo M; Orfao A; Escribano L
J Allergy Clin Immunol; 2016 Jan; 137(1):168-178.e1. PubMed ID: 26100086
[TBL] [Abstract][Full Text] [Related]
8. Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis.
Berezowska S; Flaig MJ; Ruëff F; Walz C; Haferlach T; Krokowski M; Kerler R; Petat-Dutter K; Horny HP; Sotlar K
Mod Pathol; 2014 Jan; 27(1):19-29. PubMed ID: 23807778
[TBL] [Abstract][Full Text] [Related]
9. Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin?
Lange M; Żawrocki A; Nedoszytko B; Wasąg B; Niedoszytko M; Jassem E; Nowicki R; Żmijewski MA; Biernat W
Int Arch Allergy Immunol; 2014; 165(2):104-10. PubMed ID: 25402852
[TBL] [Abstract][Full Text] [Related]
10. Kit Mutations: New Insights and Diagnostic Value.
Falchi L; Verstovsek S
Immunol Allergy Clin North Am; 2018 Aug; 38(3):411-428. PubMed ID: 30007460
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous Mastocytosis in Adults and Children: New Classification and Prognostic Factors.
Matito A; Azaña JM; Torrelo A; Alvarez-Twose I
Immunol Allergy Clin North Am; 2018 Aug; 38(3):351-363. PubMed ID: 30007456
[TBL] [Abstract][Full Text] [Related]
12. c-KIT-Positive Fatal Diffuse Cutaneous Mastocytosis With Systemic Manifestations in a Neonate.
Chaudhary N; Shapiro N; Bhutada A; Rastogi S
J Pediatr Hematol Oncol; 2019 Jul; 41(5):e338-e340. PubMed ID: 30067557
[TBL] [Abstract][Full Text] [Related]
13. Mastocytosis.
Abid A; Malone MA; Curci K
Prim Care; 2016 Sep; 43(3):505-18. PubMed ID: 27545739
[TBL] [Abstract][Full Text] [Related]
14. Detection of KIT D816V in peripheral blood of children with manifestations of cutaneous mastocytosis suggests systemic disease.
Carter MC; Bai Y; Ruiz-Esteves KN; Scott LM; Cantave D; Bolan H; Eisch R; Sun X; Hahn J; Maric I; Metcalfe DD
Br J Haematol; 2018 Dec; 183(5):775-782. PubMed ID: 30488427
[TBL] [Abstract][Full Text] [Related]
15. An Unusual Transition from Cutaneous to Systemic Mastocytosis in a Pediatric Patient.
Patel K; Cuervo-Pardo L; Cresoe S; Cavero-Chavez V
Pediatr Allergy Immunol Pulmonol; 2023 Dec; 36(4):150-152. PubMed ID: 38134319
[No Abstract] [Full Text] [Related]
16. [Mastocytosis in children].
Wassmer H; Hartmann K
Dermatologie (Heidelb); 2023 May; 74(5):323-329. PubMed ID: 37140636
[TBL] [Abstract][Full Text] [Related]
17. [Clinical observations in cutan mastocytosis].
Mihalik N; Hidvégi B; Hársing J; Várkonyi J; Csomor J; Kovalszky I; Marschalkó M; Kárpáti S
Orv Hetil; 2013 Sep; 154(37):1469-75. PubMed ID: 24016753
[TBL] [Abstract][Full Text] [Related]
18. Mast cell sarcoma of the scalp: the first sign of undisclosed systemic mastocytosis?
Falleti J; Borgia L; Lalinga AV; De Cecio R; Natella V; Patitucci G; Vita G
Pathol Res Pract; 2012 Nov; 208(11):683-6. PubMed ID: 22963840
[TBL] [Abstract][Full Text] [Related]
19. A case report on concurrent occurrence of systemic mastocytosis and myeloid sarcoma presenting with extensive skin involvements and the results of genetic study.
Wang X; Zhang L; Zhou D; Cai H; Wang X; Jiang X
Medicine (Baltimore); 2020 Dec; 99(50):e21948. PubMed ID: 33327223
[TBL] [Abstract][Full Text] [Related]
20. How I treat patients with indolent and smoldering mastocytosis (rare conditions but difficult to manage).
Pardanani A
Blood; 2013 Apr; 121(16):3085-94. PubMed ID: 23426950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
